New patent for Global Blood drug OXBRYTA

Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are eight patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…


Which pharmaceutical companies have the most suspension dosed drugs?

This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have the mos…


Biotechblog